Minnesota Mother Awarded $65.5 Million in Talcum Powder Mesothelioma Lawsuit

A Minnesota jury has awarded $65.5 million in damages to Anna Jean Houghton Carley, a 37-year-old mother of three who says she developed mesothelioma after using Johnson & Johnson’s talcum powder products throughout her childhood. The verdict, delivered following a 13-day trial in Ramsey County District Court, represents another significant legal defeat for the pharmaceutical giant in the ongoing talcum powder cancer litigation.

The Talcum Powder Cancer Verdict

In this latest talcum powder cancer trial in Minnesota, the jury determined that Johnson & Johnson’s talc-based products exposed Carley to asbestos, contributing to her development of mesothelioma, an aggressive cancer affecting the lining of the lungs. This rare form of cancer is primarily associated with asbestos exposure and carries a poor prognosis for most patients diagnosed with the condition.

During the trial, Carley’s legal team presented evidence suggesting that Johnson & Johnson marketed and sold talc-based products despite allegedly knowing they could be contaminated with asbestos. Her attorneys emphasized that the family was never warned about these potential health risks while using the product on their child.

The $65.5 million in compensation reflects the jury’s assessment of damages related to medical expenses, pain and suffering, and the profound life impact of a terminal cancer diagnosis for a young mother of three children.

Johnson & Johnson’s Response and Plans to Appeal

Following the substantial verdict in Minnesota, Johnson & Johnson announced plans to appeal the decision. Erik Haas, worldwide vice president of litigation for the company, stated that their baby powder is safe, does not contain asbestos, and does not cause cancer.

“These lawsuits are predicated on questionable scientific claims that have been refuted by decades of studies demonstrating Johnson & Johnson’s Baby Powder is safe,” Haas stated after the verdict was announced.

The company has consistently disputed allegations about asbestos contamination in its talc products, arguing that comprehensive testing and research support their safety. Despite these assertions, juries across multiple jurisdictions have sided with plaintiffs who allege harm from long-term talcum powder use.

Mesothelioma and Its Alleged Connection to Talc

Mesothelioma is a particularly aggressive form of cancer that develops in the thin layer of tissue covering many internal organs, most commonly in the lungs. The disease is almost exclusively linked to asbestos exposure, with symptoms typically appearing 20-50 years after initial exposure.

The alleged connection between talcum powder and asbestos exposure centers on the mining process. Talc, a naturally occurring mineral, can sometimes be found near asbestos deposits in the earth. Critics argue that this proximity created opportunities for cross-contamination during talc extraction and processing.

In individuals exposed to asbestos, the microscopic fibers can become lodged in lung tissue, potentially causing cellular damage that may lead to cancer development. Mesothelioma treatments often include aggressive surgery, radiation, and chemotherapy, yet the disease remains largely incurable with a median survival time of 12-21 months after diagnosis.

Ongoing Johnson & Johnson Talcum Powder Litigation

The Minnesota verdict adds to a growing number of substantial jury awards against Johnson & Johnson in talcum powder cancer lawsuits. Earlier this month, a Los Angeles jury awarded $40 million to two women who claimed the company’s talcum powder caused their ovarian cancer.

In October 2025, another California jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died of mesothelioma, raising allegations similar to Carley’s that baby powder contaminated with asbestos caused her illness.

These verdicts highlight the ongoing legal challenges the company faces despite its efforts to resolve talc litigation through various strategies. 

J&J’s Bankruptcy Strategy and Legal Maneuvering

Johnson & Johnson has pursued several controversial legal strategies in an effort to manage its talc liability exposure. The company attempted to resolve claims through a subsidiary bankruptcy approach, creating a separate entity to absorb liability and then placing that entity into bankruptcy proceedings.

This bankruptcy tactic, known as the “Texas Two-Step,” was designed to cap liability and end jury trials related to talcum powder cancer claims. However, courts have repeatedly rejected these efforts, forcing the company back into traditional litigation channels where juries continue to hear individual claims.

The failure of these bankruptcy maneuvers has left Johnson & Johnson facing thousands of individual lawsuits nationwide, with the Minnesota verdict demonstrating that substantial jury awards remain a significant risk for the company.

Understanding Talc’s Alleged Safety Risks 

The scientific community remains divided on whether talcum powder contains asbestos and whether it causes cancer. Johnson & Johnson points to numerous studies supporting their products’ safety, while plaintiffs cite internal company documents and independent testing suggesting potential contamination issues.

Regulatory bodies have also reached different conclusions. The International Agency for Research on Cancer classifies genital use of talc-based body powder as “possibly carcinogenic,” while other agencies have been more cautious about establishing definitive links.

For those affected by mesothelioma, ovarian cancer, and other illnesses allegedly related to talcum powder, litigation represents more than financial compensation. Many plaintiffs express a desire for corporate accountability and improved safety standards that might protect future consumers from similar harms.